Similar articles

• Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.

  Kumar S, de Lusignan S, McGovern A, Correa A, Hriskova M, Gatenby P, Jones S, Goldsmith D, Camm AJ. Kumar S, et al. BMJ. 2018 Feb 14;360:k342. doi: 10.1136/bmj.k342. BMJ. 2018. PMID: 29444881
• [Anticoagulation with atrial fibrillation].

  Zellerhoff S, Goette A, Kirchhof P. Zellerhoff S, et al. Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):89-94. doi: 10.1007/s00399-006-0515-z. Herzschrittmacherther Elektrophysiol. 2006. PMID: 16786467 Review. German.
• Overcoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.

  Massaro A, Giugliano RP, Norrving B, Oto A, Veltkamp R. Massaro A, et al. Int J Stroke. 2016 Dec;11(9):950-967. doi: 10.1177/1747493016660106. Epub 2016 Oct 4. Int J Stroke. 2016. PMID: 27703066 Review.
• Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.

  Djukic M, Braun LM, Unkel S, Jacobshagen C, Nau R. Djukic M, et al. Drugs Aging. 2018 Sep;35(9):859-869. doi: 10.1007/s40266-018-0571-1. Drugs Aging. 2018. PMID: 30066299
• 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

  Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP. Lip GY, et al. Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28. Am J Med. 2014. PMID: 24486284